Pegvisomant
培维索孟
Report date: 2024/06/06 13:59:09
First In Class
Base Information
Drug NamePegvisomant
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2002/11/12
Country/Territory +[4]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentPfizer IncPharmacia +[4]
Inactive CompaniesUniversity Of California San FranciscoNational Institute Of Dental And Craniofacial Research (Nidcr)
Active Indications
Inactive Indications +[4]